(Q45753524)

15 December 2017

meta-analysis

0 references

title

Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials (English)

1 reference

15 December 2017

0 references

1 reference

1 reference

Sonia K Michail

1

1 reference

15 December 2017

Adrienne Stolfi

series ordinal

2

1 reference

15 December 2017

Thomas Johnson

series ordinal

3

1 reference

15 December 2017

Gary M Onady

series ordinal

4

1 reference

15 December 2017

publication date

1 November 2008

1 reference

15 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

15 December 2017

volume

101

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

508-516

1 reference

15 December 2017

The prevalence of atopic dermatitis in Oregon schoolchildren

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Treatment principles of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Importance of genetic factors in the etiology of atopic dermatitis: a twin study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Outcome measures of disease severity in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

How atopic is atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Molecular and cellular basis of microflora-host interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics: effects on immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics: a novel approach in the management of food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics in the management of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Effects of probiotics on atopic dermatitis: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Is the effect of probiotics on atopic dermatitis confined to food sensitized children?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

What are the best outcome measurements for atopic eczema? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Empirical assessment of effect of publication bias on meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow's milk allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960290-6

7 January 2021

10.1016/S1081-1206(10)60290-6

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017